Breaking News, Promotions & Moves

Charnwood Molecular Names Francesca Sadler Chief Commercial Officer

Sadler brings 20 years of commercial experience in the discovery and development CRO field.

Charnwood Molecular has appointed Francesca Sadler Chief Commercial Officer (CCO). Sadler will lead all commercial activities across business development, sales, and marketing. Charnwood Molecula is a pre-clinical CRO specializing in enhancing the experience and success of complex drug discovery for clients globally. “Charnwood Molecular continues to see strong growth in its drug discovery services as our clients look to partner with our highly skilled and experienced team,” said Lee Patterso...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters